Huatai United Securities Co., Ltd.\'s inspection opinion on the departure of core technical personnel of Nanjing Novizan Biotechnology Co., Ltd.
Announcement of Resolutions of the 9th Meeting of the 2nd Board of Supervisors of Novizam
Resolutions of the first meeting of the 2nd Special Meeting of Independent Directors of the Board of Directors
Novi Zan\'s special report on the storage and actual use of funds raised for the 2024 semi-year
Semi-annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Focus on Return” Special Action Plan
Novozymes Investor Relations Activity Record for August 2024.
Notice from Nouveau Health regarding the voluntary disclosure of its subsidiaries' products obtaining CE IVDR certification from the European Union.
Huatai United Securities Co., Ltd.'s 2023 continuous supervision work site inspection report on Nanjing Novizan Biotechnology Co., Ltd.
Novi Zan's announcement on participating in the 2023 Biological Products Special Group Results Briefing and the First Quarter 2024 Results Briefing
Announcement of Resolutions of the Eighth Meeting of the 2nd Board of Supervisors of Novizam
Lixin Certified Public Accountants (Special General Partnership) Audit Report on the 2023 Operating Income Deduction Statement of Nanjing Novizan Biotechnology Co., Ltd.
2023 Independent Director Debriefing Report (Dong Wei)
2023 Independent Director Debriefing Report (Xia Kuanyun)
Prior approval and independent opinions of independent directors on matters relating to the 9th meeting of the 2nd Board of Directors
Special note by independent directors on the external guarantee situation in 2023
Announcement of Resolutions of the 9th Meeting of the 2nd Board of Directors of Novizam
Announcement of Resolutions of the 7th Meeting of the 2nd Board of Supervisors of Novizam
Novi Zan's announcement on renewing the employment of an accounting firm
Huatai United Securities Co., Ltd.'s verification opinion on the extension of Nanjing Novizan Biotechnology Co., Ltd.'s fund-raising investment project
Rules of Procedure for the General Meeting of Shareholders (Revised in April 2024)
No Data
No Data